Spine surgery is technically demanding, anatomically unforgiving, and clinically consequential. Patients arrive with complex pain histories and high expectations. Surgeons need instruments and implants that match the precision the environment demands. SurGenTec was built with that reality in mind.
SurGenTec is a privately owned medical device company headquartered in Boca Raton, Florida, focused on developing and manufacturing innovative products with patient and surgeon safety at the center of its design process. The company collaborates directly with experienced surgeons and leading experts to continuously improve the design and engineering of its products, a philosophy that shows up clearly in how each product in its portfolio is structured.
SI joint fusion: the TILINK-P system
Sacroiliac joint dysfunction is a significant source of lower back and pelvic pain, and SI joint fusion is an increasingly common surgical solution. The TILINK-P is SurGenTec's minimally invasive SI joint fusion system, designed for a true posterior approach with a novel transfixing compression anchor.
Key features of the TILINK-P include Nanotex Surface Technology, a hydrophilic surface that uses ionic bonds to attract and hold bone marrow aspirate and other fluids that may contain key growth factors. The system's open trellis design incorporates 500 to 750 micron openings to help promote bony ingrowth throughout the screw. The design is engineered to resist all SI joint forces including shear, nutation, counter-nutation, compression, and distraction, and allows for up to 5cc of biologic post-packing.
Cervical stabilization: the ION-C system
The ION-C is SurGenTec's posterior cervical facet fixation system, designed for controlled, non-impact placement and precise stabilization across one or two levels from C3 to C7. It features a zero-profile implant design, in-situ implant depth adjustment, and no percussion on insertion, which maintains a neutral joint position and minimizes the risk of joint expansion.
The ION-C also incorporates Nanotex Surface Technology for osseointegration promotion, with fenestrations and open barrels designed to allow bone graft integration and fusion. Instrument configurations include both single-use sterile and reusable non-sterile options to fit different facility preferences.
Bone grafting: the OsteoFlo family
SurGenTec's OsteoFlo product line addresses bone void filling across spine and extremity applications. OsteoFlo HydroFiber is FDA-cleared as equivalent to autograft across all levels of the spine and is uniquely indicated for use in cases involving tumors, cysts, osteomyelitis, fractures, and trauma. Its web interlace technology produces web-like fibers interwoven with porous synthetic particles that, when hydrated, form a cohesive structure that enhances handling and resists migration under irrigation.
The broader OsteoFlo family includes NanoPutty and HydroPutty formulations, giving surgeons multiple consistency and delivery options depending on the specific case requirements. SurGenTec also offers the GraftGun for controlled biologic delivery and the 3D GraftRasp for graft site preparation.
A portfolio built around one principle
SurGenTec describes its mission as developing intuitive solutions to improve the quality of life for patients, and the product portfolio reflects that directly. Each system is designed to reduce complexity in the OR, support the body's natural healing processes, and give surgeons reliable options for procedures where precision matters most. Synchrocare distributes SurGenTec products as part of its national medical device portfolio, supporting surgeons and healthcare facilities with trained clinical representation.
To learn more about SurGenTec products available through Synchrocare, visit www.synchrocare.com.